Jason De Melo

1.2k citations
20 papers · 854 indexed · h-index 13
Topics
Ubiquitin and proteasome pathways (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)
Partner nations
CanadaUnited StatesChina

In The Last Decade

Jason De Melo

20 papers receiving 843 citations

Peers

Jason De Melo
Comparison fields: 5 of 75
  • Molecular Biology 658
  • Cancer Research 311
  • Oncology 231
  • Pulmonary and Respiratory Medicine 94
  • Cell Biology 58
Replace Hefen Sun with:
Hefen Sun China
Lei Zhan China
Yidan Ren China
Sandra E. Ghayad France
Xiaohui Pan China
Abhik Mukherjee United Kingdom
Weiguo Wu United States
Haijun Zhang China
Anna Frenzel Sweden
Hye Gyeong Park South Korea
Jason De Melo relative to Hefen Sun China Hefen Sun's profile →
Citations per field
00.5×1.5×
Hefen Sun · 1×
Citations per year

Countries citing papers authored by Jason De Melo

Since Specialization
Citations

This map shows the geographic impact of Jason De Melo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason De Melo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason De Melo more than expected).

Fields of papers citing papers by Jason De Melo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason De Melo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason De Melo. The network helps show where Jason De Melo may publish in the future.

Co-authorship network of co-authors of Jason De Melo

This figure shows the co-authorship network connecting the top 25 collaborators of Jason De Melo. A scholar is included among the top collaborators of Jason De Melo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason De Melo. Jason De Melo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 17
2 2
3 44
4 20
5 5
6
Enhancing Two-stage Collaborative Exams by Incorporating Immediate Feedback
1
7 285
8 22
9 40
10 5
11 28
12 12
13 34
14 17
15 59
16 9
17 6
18 11
19 195
20 42

About Jason De Melo

Jason De Melo is a scholar working on Cancer Research, Molecular Biology and Modeling and Simulation, having authored 20 papers that have together received 854 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Cancer Research (311 citations), Molecular Biology (658 citations) and Oncology (231 citations). Jason De Melo has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Damu Tang, Nicholas Wong, Corey Lourenco, Linda Z. Penn, Manpreet Kalkat, Diana Resetca, William B. Tu, Judy Yan, Jean‐Claude Cutz and Tariq Aziz. Their work appears in journals such as Nature Communications, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026